Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Clin Infect Dis ; 73(7): e1601-e1610, 2021 10 05.
Artículo en Inglés | MEDLINE | ID: mdl-32970811

RESUMEN

BACKGROUND: We determined whether an audit on the adherence to guidelines for hospital-acquired pneumonia (HAP) can improve the outcomes of patients in intensive care units (ICUs). METHODS: This study was conducted at 35 ICUs in 30 hospitals. We included consecutive, adult patients hospitalized in ICUs for 3 days or more. After a 3-month baseline period followed by the dissemination of recommendations, an audit on the compliance to recommendations (audit period) was followed by a 3-month cluster-randomized trial. We randomly assigned ICUs to either receive audit and feedback (intervention group) or participate in a national registry (control group). The primary outcome was the duration of ICU stay. RESULTS: Among 1856 patients enrolled, 602, 669, and 585 were recruited in the baseline, audit, and intervention periods, respectively. The composite measures of compliance were 47% (interquartile range [IQR], 38-56%) in the intervention group and 42% (IQR, 25-53%) in the control group (P = .001). As compared to the baseline period, the ICU lengths of stay were reduced by 3.2 days in the intervention period (P = .07) and by 2.8 days in the control period (P = .02). The durations of ICU stay were 7 days (IQR, 5-14 days) in the control group and 9 days (IQR, 5-20 days) in the intervention group (P = .10). After adjustment for unbalanced baseline characteristics, the hazard ratio for being discharged alive from the ICU in the control group was 1.17 (95% confidence interval, .69-2.01; P = .10). CONCLUSIONS: The publication of French guidelines for HAP was associated with a reduction of the ICU length of stay. However, the realization of an audit to improve their application did not further improve outcomes. CLINICAL TRIALS REGISTRATION: NCT03348579.


Asunto(s)
Neumonía Asociada a la Atención Médica , Unidades de Cuidados Intensivos , Adulto , Cuidados Críticos , Hospitales , Humanos , Tiempo de Internación
2.
Crit Care Med ; 49(9): e870-e873, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-34049307

RESUMEN

OBJECTIVES: To describe the successful recovery from multiple and life-threatening venous thrombosis after ChAdOx1 nCoV-19 vaccination. DESIGN: Case report. SETTING: University Hospital. PATIENT: Few days after the first dose of the ChAdOx1 nCoV-19 vaccine, a 21-year-old woman experienced massive thrombosis in the deep and superficial cerebral veins together with seizures, neurologic focal deficit, and thrombocytopenia. In the neurointensive care unit, her condition worsened despite early decompressive craniectomy. She developed bilateral segmental pulmonary embolism, left hepatic, and left external iliac venous thrombosis. INTERVENTION: Argatroban (0.5-2.2 µg/kg/min) and high-dose IV immunoglobulin (1 g/kg/d for 2 consecutive days) were initiated on day 6 after admission. With these therapies, there was a gradual resolution of multiple sites of venous thrombosis, and platelet count returned to normal. The patient left the ICU with full consciousness, expressive aphasia, and right hemiparesis. CONCLUSIONS: This case of vaccine-induced immune thrombotic thrombocytopenia shows that a good outcome can be obtained even with multiple and life-threatening venous thrombotic lesions. Argatroban and high-dose IV immunoglobulin along with management of severe cerebral venous thrombosis played a major role in this epilogue.


Asunto(s)
Antitrombinas/uso terapéutico , Arginina/análogos & derivados , Vacunas contra la COVID-19/efectos adversos , Ácidos Pipecólicos/uso terapéutico , Sulfonamidas/uso terapéutico , Trombocitopenia/tratamiento farmacológico , Trombosis de la Vena/tratamiento farmacológico , Arginina/uso terapéutico , Venas Cerebrales/diagnóstico por imagen , ChAdOx1 nCoV-19 , Quimioterapia Combinada , Femenino , Fondaparinux/uso terapéutico , Humanos , Inmunoglobulinas Intravenosas , Trombocitopenia/etiología , Tomografía Computarizada por Rayos X , Trombosis de la Vena/etiología , Adulto Joven
3.
Anesth Analg ; 133(3): 723-730, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-33780388

RESUMEN

BACKGROUND: Chest injuries are associated with mortality among patients admitted to the intensive care unit (ICU) and require multimodal pain management strategies, including regional anesthesia (RA). We conducted a survey to determine the current practices of physicians working in ICUs regarding RA for the management of chest trauma in patients with multiple traumas. METHODS: An online questionnaire was sent to medical doctors (n = 1230) working in French ICUs, using the Société Française d'Anesthésie Réanimation (SFAR) mailing list of its members. The questionnaire addressed 3 categories: general characteristics, practical aspects of RA, and indications and contraindications. RESULTS: Among the 333 respondents (response rate = 27%), 78% and 40% of 156 respondents declared that they would consider using thoracic epidural analgesia (TEA) and thoracic paravertebral blockade (TPB), respectively. The main benefits declared for performing RA were the ability to have effective analgesia, a more effective cough, and early rehabilitation. For 70% of the respondents, trauma patients with a theoretical indication of RA did not receive TEA or TPB for the following reasons: the ICU had no experience of RA (62%), no anesthesiologist-intensivist working in the ICU (46%), contraindications (27%), ignorance of the SFAR guidelines (19%), and no RA protocol available (13%). In this survey, 95% of the respondents thought the prognosis of trauma patients could be influenced by the use of RA. CONCLUSIONS: While TEA and TPB are underused because of several limitations related to the patterns of injuries in multitrauma patients, lack of both experience and confidence in combination with the absence of available protocols appear to be the major restraining factors, even if physicians are aware that patients' outcomes could be improved by RA. These results suggest the need to strengthen initial training and provide continuing education about RA in the ICU.


Asunto(s)
Analgesia/tendencias , Anestesia de Conducción/tendencias , Unidades de Cuidados Intensivos/tendencias , Traumatismo Múltiple/terapia , Manejo del Dolor/tendencias , Pautas de la Práctica en Medicina/tendencias , Traumatismos Torácicos/terapia , Heridas no Penetrantes/terapia , Analgesia/efectos adversos , Anestesia de Conducción/efectos adversos , Francia/epidemiología , Encuestas de Atención de la Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Traumatismo Múltiple/diagnóstico , Traumatismo Múltiple/epidemiología , Manejo del Dolor/efectos adversos , Traumatismos Torácicos/diagnóstico , Traumatismos Torácicos/epidemiología , Factores de Tiempo , Resultado del Tratamiento , Heridas no Penetrantes/diagnóstico , Heridas no Penetrantes/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA